13F Portfolios

Darwin Global Management, Ltd.: REVOLUTION MEDICINES INC (RVMD): Quarterly 13F Position History

As of Q2 2026, Darwin Global Management, Ltd. reported 10,629,822 shares of REVOLUTION MEDICINES INC (RVMD), worth $2.0B and representing 54.5% of its 13F equity book. Quarter-over-quarter share count change: + 8,418,804 (+380.8%) . The position first appeared in Q1 2026 and has been disclosed across 2 13F-HR filings in Pactolio's tracked window.

Recent initiation: Darwin Global Management, Ltd. first reported RVMD on the Q1 2026 filing, so fewer than three quarters of history are available.

Quarterly 13F-HR Disclosure History Source: SEC 13F-HR filings, 2 quarter s

Quarter Shares QoQ Share Change Share Change (%) Market Value Weight Implied Price
Q2 2026 10,629,822 +8,418,804 +380.8% $2.0B 54.5% $192.6
Q1 2026 2,211,018 $205.0M 5.4% $92.7

Methodology & FAQ

How This Position History Is Sourced

Each row is one SEC Form 13F-HR filing disclosing this position. Share count, market value, and reported quarter are taken verbatim from the filing; portfolio weight is recomputed against the same filing's total reported equity book. Implied price-per-share is market value divided by shares, a quarter-end mark rather than the manager's cost basis. See the full methodology document for the normalization rules.

When did Darwin Global Management, Ltd. first disclose a RVMD position in 13F-HR filings?

Darwin Global Management, Ltd. first reported REVOLUTION MEDICINES INC (RVMD) on its 13F-HR filing for the period ending 2026-03-31 (Q1 2026). The position has appeared on 2 reported quarters within Pactolio's tracked window.

What was Darwin Global Management, Ltd.'s most recent quarter-over-quarter share-count change in RVMD?

Between Q1 2026 and Q2 2026, Darwin Global Management, Ltd. added 8,418,804 shares of RVMD (+380.8%), bringing the total reported position to 10,629,822 shares at a market value of $2.0B.

Does the implied price-per-share represent Darwin Global Management, Ltd.'s cost basis in RVMD?

No. The implied price-per-share column is the 13F-HR reported market value divided by reported share count on the filing date (end of quarter). It is a quarter-end mark, not a cost basis or transaction price. Use it as a sanity check on the value column, not as an indicator of the manager's entry or exit price.